For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
System Fix: Episode 14 – On holding true, the guys from TU
This item is over 2 years old; some content may no longer be current
+Undoctored
PODCAST
System Fix: Episode 14 – On holding true, the guys from TU
Monday 4 October 2021, 02:57 PM
43 minutes to Listen

New Zealand Doctor Rata Aotearoa editor Barbara Fountain talks to Stephen McKernan, director of the Health and Disability Review Transition Unit, and his deputy, Martin Hefford. They discuss function trumping form; a crucial health plan; central agencies vs local services; communities and localities; private providers; workforce; leadership and, ultimately, selling the plan for health sector reform and convincing people to stay the course...